title: [Relevance of first trimester serum markers to predict pregnancy complications: A Tunisian preliminary study].
abstract: OBJECTIVE
  Identify applications and utility of serum markers dosed in the first trimester in predicting, early diagnosis and management of various complications of pregnancy.
  
  
  METHODS
  Eight hundred and eighty patients were included in this prospective regional study performed in the governorate of Bizerte in northern Tunisia in collaboration between the private and public sectors. Serum markers of the first quarter, PAPP A and βhCG, were measured in the same laboratory. The performance of these markers was studied in the prediction of adverse pregnancy complications.
  
  
  RESULTS
  The prevalence of various pregnancy complications was 8.6% for birth prematurely, 9.2% for hypertension or preeclampsia, IUGR 5.8% and 7.3% for loss pregnancy. PAPP A levels were lower in fetal loss group (P=0.005), vascular disease group (P=0.001) and preterm delivery group (P=0.001). In addition, a lower rate of βhCG was associated with the occurrence of placental pathologies such as growth retardation (P=0.037) and hypertension (P=0.034) and appears to have no predictive value in the occurrence of preterm birth (P=0.76) and fetal loss (P=0.189). Logistic regression analysis showed a significant predictive value of these markers.
  
  
  CONCLUSIONS
  Serum markers of the first trimester appear to have adequate predictive validity of adverse pregnancy complications. A risk predictive model could be designed based on these markers and involving maternal and ultrasound features in order to target prophylactically a high risk population.
authors: Service de gynécologie et obstétrique, hôpital Habib Bougatfa, CHU de Bizerte, rue du 13 août, 7000 Bizerte, Tunisie; Bio Dhaouadi, centre d'analyses médicales et biologie de la reproduction, 21, avenue de l'Algérie, 7000 Bizerte, Tunisie. Electronic address: arij2009@voila.fr.
authors: A
authors: A
authors: Bouzid
authors: Service de gynécologie et obstétrique, hôpital Habib Bougatfa, CHU de Bizerte, rue du 13 août, 7000 Bizerte, Tunisie; Bio Dhaouadi, centre d'analyses médicales et biologie de la reproduction, 21, avenue de l'Algérie, 7000 Bizerte, Tunisie.
authors: A
authors: A
authors: Ayachi
authors: Service de gynécologie et obstétrique, hôpital Habib Bougatfa, CHU de Bizerte, rue du 13 août, 7000 Bizerte, Tunisie; Bio Dhaouadi, centre d'analyses médicales et biologie de la reproduction, 21, avenue de l'Algérie, 7000 Bizerte, Tunisie.
authors: H
authors: H
authors: Dhaoudi
authors: Service de gynécologie et obstétrique, hôpital Habib Bougatfa, CHU de Bizerte, rue du 13 août, 7000 Bizerte, Tunisie; Bio Dhaouadi, centre d'analyses médicales et biologie de la reproduction, 21, avenue de l'Algérie, 7000 Bizerte, Tunisie.
authors: M
authors: M
authors: Mourali
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D005260:Female; D005317:Fetal Growth Retardation / Q000097:blood; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D011225:Pre-Eclampsia / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood*; D011261:Pregnancy Trimester, First; D047928:Premature Birth / Q000097:blood; D011446:Prospective Studies; D014416:Tunisia; D016216:Ultrasonography, Prenatal
chemical_list: D015415:Biomarkers; D018997:Chorionic Gonadotropin, beta Subunit, Human
keywords: Complications de la grossesse; First trimester; Marqueurs sériques; Pregnancy complications; Premier trimestre; Serum markers